These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6535546)

  • 21. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
    Leonhardt A; Strehl R; Barth H; Seyberth HW
    Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants.
    Bell EF; Warburton D; Stonestreet BS; Oh W
    N Engl J Med; 1980 Mar; 302(11):598-604. PubMed ID: 7351906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of symptomatic patient ductus arteriosus in premature infants.
    Ho LY
    J Singapore Paediatr Soc; 1986; 28(1-2):153-62. PubMed ID: 3762074
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
    Cherif A; Jabnoun S; Khrouf N
    Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When to treat the patent ductus arteriosus with indomethacin in very-low-birth-weight infants.
    Mahony L; Heymann MA; Carnero V; Brett C; Clyman RI
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():491-4. PubMed ID: 6221636
    [No Abstract]   [Full Text] [Related]  

  • 28. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of persistent ductus arteriosus in the newborn with respiratory insufficiency].
    Hurtado del Rio D; Holden Barker AM; Pezzotti MA; Gutiérrez Bosque R; Archundia A; Pérez Mejia J; Carrillo H
    Arch Inst Cardiol Mex; 1979; 49(4):662-72. PubMed ID: 485672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
    O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
    J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacologic treatment of patent ductus arteriosus in premature infants].
    Vázquez C; Cabrera A; Pastor E; Valls y Soler A
    An Esp Pediatr; 1983 Jun; 18(6):482-8. PubMed ID: 6625369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management.
    Neu J; Ariagno RL; Johnson JD; Pitlick PT; Cohen RS; Beets CL; Sunshine P
    Pediatr Pharmacol (New York); 1981; 1(3):245-9. PubMed ID: 7346744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patent ductus arteriosus in preterm infants.
    Yu VY
    Med J Aust; 1980 Aug; 2(4):175-6. PubMed ID: 7432277
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of ibuprofen in neonates in the treatment of patent ductus arteriosus.
    Van Overmeire B
    Int J Clin Pract Suppl; 2003 Apr; (135):23-7. PubMed ID: 12723743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ibuprofen: alternative treatment for patent ductus arteriosus.
    Flores M
    Neonatal Netw; 2003; 22(2):27-31. PubMed ID: 12696723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of indomethacin on closure of ductus arteriosus in very-low-birthweight neonates.
    Godambe S; Newby B; Shah V; Shah PS
    Acta Paediatr; 2006 Nov; 95(11):1389-93. PubMed ID: 17062465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of the premature infant with a patent ductus arteriosus.
    Dooley KJ
    Pediatr Clin North Am; 1984 Dec; 31(6):1159-74. PubMed ID: 6504592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of patent ductus arteriosus in premature infants by indomethacin].
    Monin P; Bianchetti G; Marchal F; Vert P; Morselli P
    Presse Med; 1987 Jun; 16(21):1035-8. PubMed ID: 2955324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure.
    Narayanan M; Cooper B; Weiss H; Clyman RI
    J Pediatr; 2000 Mar; 136(3):330-7. PubMed ID: 10700689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sepsis and indomethacin failure in premature infants with symptomatic patent ductus arteriosus.
    Salzer HR; Salzer-Muhar U; Pollak A; Weninger M
    Lancet; 1987 Apr; 1(8539):977. PubMed ID: 2882363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.